Preterm Infants: Clinical Trials

4 trials for Preterm Infants, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 31Completed 1

Follow Preterm Infants: new trials by email Literature Review of Preterm Infants trials Research Report on Preterm Infants

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lansoprazole in Preterm Infants With Reflux
Lansoprazole - Preterm Infants, Gastrointestinal Reflux
Phase 2CompletedSeoul National University Hospital52013-01-012013-09-13
Vitamin D Supplementation for Extremely Preterm Infants
Cholecalciferol, Placebo - Vitamin D Deficiency, Preterm Infants
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham1002012-06-012017-02-10
Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants
three times weekly Epo, weekly Epo - Preterm Infants
Phase 2CompletedUniversity of New Mexico202006-04-012022-06-21
Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants
Lipofundin MCT/LCT 20 %, Lipidem 20% - Preterm Infants, Parenteral Nutrition n-3 Fatty Acids
Phase 2CompletedB. Braun Melsungen AG482006-01-012021-03-10

Narrower conditions

Premature Birth (3)  ·  Anemia (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Gastroesophageal Reflux (1)  ·  Hyperphagia (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (3)  ·  Obstetric Labor Complications (3)  ·  Obstetric Labor, Premature (3)  ·  Pregnancy Complications (3)  ·  Urogenital Diseases (3)  ·  Avitaminosis (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Deficiency Diseases (1)  ·  Deglutition Disorders (1)  ·  Digestive System Diseases (1)  ·  Esophageal Diseases (1)  ·  Esophageal Motility Disorders (1)  ·  Gastrointestinal Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

Cholecalciferol (1)  ·  Epoetin Alfa (1)  ·  Lansoprazole (1)  ·  Vitamin D (1)

Sponsors

B. Braun Melsungen AG (1)  ·  Seoul National University Hospital (1)  ·  University of Alabama at Birmingham (1)  ·  University of New Mexico (1)

Countries

United States (2)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Ariel A. Salas, MD (1)  ·  Berthold V. Koletzko, Prof., MD (1)  ·  Han-Suk Kim, MD, PhD (1)  ·  Namasivayam Ambalavanan, MD (1)  ·  Robin K Ohls, MD (1)

Results publications

PMID 27079965, PMID 33305842, PMID 35728797

NIH funding

M01RR000997 (1)